Abstract
The introduction of transcatheter aortic valve implantation (TAVI) has revolutionized the treatment of patients with severe aortic stenosis by providing a minimally invasive alternative to open-heart surgery. Initially developed for patients who were considered unsuitable for open-heart surgery, TAVI has become the preferred treatment for patients aged 75 years and older, regardless of their surgical risk profile. The indication for TAVI is expected to expand further in the coming years.
The first part of this thesis focuses on the incidence and temporal trends of complications and their impact on survival. Herefor, we used data from more than 25,000 patients. The results show that severe complications requiring emergency open-heart surgery have become rare. In addition, the risk of major bleeding has declined substantially, although it still affects a considerable proportion of patients. In contrast, the incidence of stroke following TAVI has remained largely unchanged over the years.
The second part of this thesis focuses on patients with both severe aortic stenosis and coronary artery disease. For many years, patients with concomitant coronary artery disease underwent routine percutaneous coronary intervention (PCI) before TAVI. However, the randomized PRO-TAVI trial demonstrated that deferral of PCI is noninferior. Patients who did not undergo PCI before TAVI had comparable clinical outcomes, while risk of major bleeding complications was substantially lower. Importantly, only a small proportion of patients required PCI after TAVI, and these procedures could generally be performed safely without technical difficulties.
In summary, the optimal treatment of patients with severe aortic valve stenosis, with or without concomitant coronary artery disease, requires a personalized approach. The findings of this thesis contribute to a more streamlined and evidence-based treatment strategy for this growing patient population.
The first part of this thesis focuses on the incidence and temporal trends of complications and their impact on survival. Herefor, we used data from more than 25,000 patients. The results show that severe complications requiring emergency open-heart surgery have become rare. In addition, the risk of major bleeding has declined substantially, although it still affects a considerable proportion of patients. In contrast, the incidence of stroke following TAVI has remained largely unchanged over the years.
The second part of this thesis focuses on patients with both severe aortic stenosis and coronary artery disease. For many years, patients with concomitant coronary artery disease underwent routine percutaneous coronary intervention (PCI) before TAVI. However, the randomized PRO-TAVI trial demonstrated that deferral of PCI is noninferior. Patients who did not undergo PCI before TAVI had comparable clinical outcomes, while risk of major bleeding complications was substantially lower. Importantly, only a small proportion of patients required PCI after TAVI, and these procedures could generally be performed safely without technical difficulties.
In summary, the optimal treatment of patients with severe aortic valve stenosis, with or without concomitant coronary artery disease, requires a personalized approach. The findings of this thesis contribute to a more streamlined and evidence-based treatment strategy for this growing patient population.
| Original language | English |
|---|---|
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 16 Oct 2026 |
| Publisher | |
| Print ISBNs | 978-94-6537-799-5 |
| DOIs | |
| Publication status | Published - 16 Oct 2026 |
Keywords
- Aortic stenosis
- transcatheter aortic valve implantation
- complications
- coronary artery disease
- percutaneous coronary intervention
Fingerprint
Dive into the research topics of 'Transcatheter Aortic Valve Implantation: towards safer and leaner procedures'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver